Mayne Pharma Australia

Mayne Pharma Australia stands as a prominent force in pharmaceutical manufacturing, dedicated to providing customer-focused, full-service solutions as an Australian-based CDMO. Specializing in oral and topical dosage forms, Mayne Pharma Australia operates with a commitment to excellence and innovation.

Based in Salisbury South, Mayne Pharma Australia, also known as Mayne Pharma International (MPI), leverages its expertise in pharmaceutical development and scale-up to deliver cost-effective solutions from concept to commercialization. With a TGA and FDA-accredited GMP manufacturing facility, Mayne Pharma Australia is uniquely positioned to provide a gateway to global markets. Their innovative oral drug delivery systems enhance formulations and facilitate the in-licensing of novel medicines worldwide.

Mayne Pharma Australia is dedicated to improving health outcomes for patients through collaborative partnerships and a wide range of specialty prescription and consumer products. Our team is focused on delivering better health outcomes for Australian patients. We invite the management team at Mayne Pharma Australia to create a customized and exclusive company showcase and product listing on our platform to further highlight your exceptional capabilities.